Targeted molecular therapy for preventing heart failure and sudden cardiac death. 28 September 2010, New York, NY, USA.

Abstract

The targeted molecular therapy for preventing heart failure and sudden cardiac death discussion session, organized by the Biochemical Pharmacology Discussion Group of the New York Academy of Sciences and held in New York, included topics covering new research developments in the field of heart failure. This conference report highlights selected presentations on GPCRs for heart failure, calcium and heart function, and mitochondrial targets in heart failure. A summary of the panel discussion is also provided.